Plasma derivative replacement therapy in diss. intravasc.coag.(DIC) induced by septic disorders with highly elevated elastase alpha 1AT-complexes.
Egbring
R
R
Dept. of Internal Medicine, Marburg, West Germany.
Seitz
R
R
Wolf
M
M
Havemann
K
K
Lerch
L
L
Blanke
H
H
Fuchs
G
G
D000990:Antithrombin III / Q000378:metabolism; D001424:Bacterial Infections / Q000150:complications* / Q000201:enzymology; D001798:Blood Proteins / Q000032:analysis*; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000201:enzymology / Q000209:etiology* / Q000628:therapy; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007106:Immune Sera; D007122:Immunoelectrophoresis; D008297:Male; D010447:Peptide Hydrolases / Q000378:metabolism; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011480:Protease Inhibitors / Q000032:analysis*; D000515:alpha 1-Antitrypsin
D001798:Blood Proteins; D007106:Immune Sera; D010952:Plasma Substitutes; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin; C046193:antithrombin III-protease complex; D000990:Antithrombin III; D010447:Peptide Hydrolases